Randomized Trial of Neuroprotective Effects of Erythropoietin in Patients Receiving Adjuvant Chemotherapy for Breast Cancer: Position Emission Tomography and NE

Abstract

Adjuvant treatment with Adriamycin and cyclophosphamide (AC) clearly prolongs the overall survival in women with breast cancer. Cognitive deficits (e.g. problems with memory and concentration) are common during and after adjuvant breast cancer chemotherapy, but the pathophysiology of cognitive phenomens is unknown. The goal of this project is to study the pathophysiology of cognitive dysfunction in patients receiving adjuvant treatment using Positron Emission Tomography (PET) scan.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 01, 2006
Accession Number
ADA460291

Entities

People

  • James Abraham

Organizations

  • West Virginia University

Tags

Communities of Interest

  • Materials and Manufacturing Processes

DTIC Thesaurus Topics

  • Animals
  • Blood
  • Blood Flow
  • Brain
  • Brain Injuries
  • Breast Cancer
  • Chemotherapy
  • Cognitive Impairment
  • Cytokines
  • Drug Therapy
  • Dysfunction
  • Neoplasms
  • Pathophysiology
  • Positron Emission Tomography
  • Positron Emissions
  • Psychological Tests
  • Tomography

Fields of Study

  • Medicine

Readers

  • Medical Imaging.
  • Neuroscience
  • Oncology (Cancer Research).